- CSR Summary Not Available
- NCT00035802
- Primary Citation Trial has yet to be published
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaBehaviors and Mental DisordersEnrollment13% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-PDMD-009Data PartnerJohnson & JohnsonCondition StudiedBipolar DisorderMean/Median Age (Years)N/A
Supporting Documentation
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the protocol with amendments and clinical study report are available.